To evaluate the long-term outcomes of infective endocarditis (IE) in people who inject drugs (PWID) compared to non-PWID with community-acquired IE, emphasizing the comparative aspect.
Key Findings:
15 PWID experienced a new IE episode within 5 years compared to 5 non-PWID (OR 4.65; P = .003), highlighting the increased risk for PWID.
One-year all-cause mortality was similar: 4.0% in PWID and 4.1% in non-PWID, indicating comparable short-term outcomes.
Five-year all-cause mortality was 18.7% in PWID and 13.3% in non-PWID (P = .399), suggesting a concerning trend for PWID.
Injection drug use, female gender, and higher comorbidity index were independent factors associated with death, underscoring the need for targeted interventions.
Interpretation:
Long-term survival for PWID with IE is poor, with a higher risk of new IE episodes compared to non-PWID, indicating a need for improved addiction treatment and clinical interventions.
Limitations:
Retrospective design may introduce bias, particularly in self-reported data.
Limited generalizability due to the specific population studied, which may not reflect broader trends.
Conclusion:
The study highlights the poor long-term outcomes for PWID with IE and emphasizes the necessity for enhanced addiction treatment strategies to improve patient outcomes.
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
